Does UMBRALISIB Cause Disease progression? 30 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 30 reports of Disease progression have been filed in association with UMBRALISIB. This represents 10.2% of all adverse event reports for UMBRALISIB.
30
Reports of Disease progression with UMBRALISIB
10.2%
of all UMBRALISIB reports
2
Deaths
3
Hospitalizations
How Dangerous Is Disease progression From UMBRALISIB?
Of the 30 reports, 2 (6.7%) resulted in death, 3 (10.0%) required hospitalization, and 1 (3.3%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UMBRALISIB. However, 30 reports have been filed with the FAERS database.
What Other Side Effects Does UMBRALISIB Cause?
Diarrhoea (47)
Nausea (36)
Fatigue (30)
Covid-19 (16)
Nervous system disorder (15)
Death (14)
Asthenia (13)
Off label use (13)
Product dose omission issue (12)
Anaemia (11)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which UMBRALISIB Alternatives Have Lower Disease progression Risk?
UMBRALISIB vs UMECLIDINIUM
UMBRALISIB vs UMECLIDINIUM\VILANTEROL TRIFENATATE
UMBRALISIB vs UMIFENOVIR
UMBRALISIB vs UNSPECIFIED INGREDIENT
UMBRALISIB vs UPADACITINIB